Georgia State University named on June 2, 2022, the awardees of the first-ever Research Innovation and Scholarly Excellence (RISE) challenge. They will conduct research under four dynamic research hubs, and each group will receive one-time seed funding of up to $750,000 over the course of one year to fund their work.
Georgia State University will launch a new Research Innovation and Scholarly Excellence (RISE) challenge to address complex societal problems through interdisciplinary collaboration. The initiative aims to foster an innovative research ecosystem at the university and leverage the strengths of the Georgia State research community to address complex problems.
The Center for Translational Antiviral Research has been established in the Institute for Biomedical Sciences at Georgia State University to fill the gap for developing affordable, much-needed antiviral drugs that will reduce severe viral diseases and meet the threats imposed by existing and newly evolving viruses.
Georgia State University faculty have earned $142 million in research funding in fiscal year 2021, the third highest total in university history. Thirty-seven faculty members were awarded more than $1 million, a university record. Among the university’s top 20 grant recipients, half are women.
COVID-19 patients who receive oxygen therapy or experience fever show reduced gray matter volume in the frontal-temporal network of the brain, according to a new study led by researchers at Georgia State University and the Georgia Institute of Technology.
The study found lower gray matter volume in this brain region was associated with a higher level of disability among COVID-19 patients, even six months after hospital discharge.
Gray matter is vital for processing information in the brain and gray matter abnormality may affect how well neurons function and communicate.
Khayla McClinton, a master’s student in the Institute for Biomedical Sciences, wants to close the health access gap and bring the voice of underrepresented communities to conversations about research, discoveries and prevention.
A novel form of macrophage-based immunotherapy is effective at treating a broad spectrum of cancers, including those at advanced stages, according to a groundbreaking study led by Georgia State immunology professor Yuan Liu.
The pandemic took a heavy toll on the learning gains of metro Atlanta’s students, according to new research by Georgia State University’s Metro Atlanta Policy Lab for Education (MAPLE).
Georgia State University’s Evidence-Based Cybersecurity Research Group (ECBS) will use a $1.4 million federal Minerva Research Initiative grant to examine the growing threat of conspiracy theories and how they lead to radicalization and acts of violence.
Georgia State University has introduced the Advanced Research Computing Technology & Innovation Core (ARCTIC) to support research that would not be possible with standard consumer-grade computing, including analysis, modeling, simulation and the prediction of complex phenomena.
